Background and Objective: Melatonin deficiency has been associated with obesity and systemic inflammation. This study aims to evaluate whether melatonin could interfere with the mechanisms of co-morbidity linking obesity and periodontitis.
Material and Methods:
Twenty-eight male Wistar rats were randomly divided in 4 groups: control group (Con) (fed with standard diet); high-fat diet group (HFD) (fed with a diet containing 35.2% fat); Con group with induced periodontitis (Con-Perio) and HFD group with induced periodontitis (HFD-Perio). To induce periodontitis, the method of oral gavages with Porphyromonas gingivalis ATCC W83K1 and Fusobacterium nucleatum DMSZ 20482 was used. Circulating melatonin levels were analyzed by multiplex immunoassays. Periodontitis was assessed by alveolar bone loss (microcomputed tomography and histology) and by surrogate inflammatory outcomes (periodontal pocket depth, modified gingival index and plaque dental index).
Results: Plasma melatonin levels were significantly decreased (P < .05) in the obese rats with periodontitis when compared with controls or with either obese or periodontitis rats. Alveolar bone loss increased 27.71% (2.28 µm) in HFD-Perio group compared with the Con group. The histological analysis showed marked periodontal tissue destruction with osteoclast activity, particularly in the HFD-Perio group. A significant negative correlation (P < .05) was found between periodontal pocket depth, modified gingival index and circulating melatonin levels.
Conclusion:
Obese and periodontitis demonstrated significantly lower melatonin concentrations when compared with controls, but in obese rats with periodontitis these concentrations were even significantly lower when compared with either periodontitis or obese rats. These results may indicate that melatonin deficiency could be a key mechanism explaining the co-morbidity effect in the association between obesity and periodontitis.
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To explain the plausible biological mechanisms linking both diseases, experimental studies have combined experimental obesity and periodontitis. These studies, although pointing to some possible mechanisms, have not identified a clear pathogenic pathway. [2] [3] [4] [5] [6] A recent experimental study from our research group has shown the co-morbidity effect by demonstrating a significant elevation of the biomarkers associated with systemic inflammation, metabolic dysregulation and periodontal destruction when both disease processes coexisted, compared to each independently. 7 Other studies have hypothesized that this co-morbidity effect could be influenced by the circadian cycle 8 and by melatonin, as a key molecular modulator of this cycle. 9 Furthermore, melatonin optimizes the energy balance and body weight regulation 10 and reduced circulating levels of melatonin have been associated with obesity. 11 Similarly, reduced levels of melatonin in saliva and gingival crevicular fluid have been associated with patients with chronic periodontitis, 12 mainly in the most aggressive forms of periodontitis. 13, 14 In spite of these facts, the possible role of the lack of melatonin as a co-morbidity effect in obesity and periodontitis, remains unknown.
It was, therefore, the purpose of this in-vivo investigation to study the impact of experimental obesity and periodontitis on the melatonin plasma levels.
| MATERIAL AND ME THODS

| Animals and experimental design
This preclinical in vivo investigation used Wistar rats and had a randomized block, examiner blind experimental design, following the ARRIVE guidelines. 15 A recent investigation using the same experimental design has been recently published by our research group, where the methods of animal care and maintenance, anesthesia and experimental induction of periodontitis and obesity are described in detail. 16 In brief, experimental induction of obesity was done first by randomly distributing the experimental animals in to 2 groups (n = 14); 1 receiving a high-fat diet (TD 03307) (HFD group) and the other a control standard diet (C group) ad libitum (Harlam Ibérica, Barcelona, Spain) ( Table 1) . Food intake was controlled daily and all animals were weekly weighed. Obesity was diagnosed after approximately 60 days in the group consuming the high-fat diet, with the difference in body weight between groups at this time of at least 15%. 17 Once obesity was attained in the HFD group, both groups were randomly distributed in to 2 further groups, with or without experimental periodontitis. Experimental periodontitis was induced following a previously validated protocol 18 where 2 periodontal pathogens, Porphyromonas gingivalis (strain ATCC W83) and Fusobacterium nucleatum strain (DMSZ 20482), were administered in solution by the oral gavage method. 19 In brief, a mix of the 2 bacteria (10 9 cells per ml, adjusted by spectrophotometry at 550 nm) was re-suspended in sterile 2% carboxy-methyl-cellulose (Sigma, St. Louis, MO, USA).
One milliliter of this suspension was administered with a sterile syringe without anesthesia, 4 consecutive days during 12 weeks. were studied by micro-computed tomography (microCT) analysis and by histology once decalcified, dehydrated and embedded in paraffin.
| Micro-computed tomography
The hemi-mandibles were scanned by a high-resolution microCT system (Skyscan 1172; Bruker microCT, Kontich, Belgium) at 4.96 μm voxel resolution using a source voltage of 100 kV and a current of 100 μA with a 0.5 mm aluminum and copper filter to optimize contrast.
The resulting images of teeth were rotated 360° around their long axes and 4 absorption images were recorded every 0.400° of rotation.
These raw images were then reconstructed with the standard SkyScan reconstruction software (NRecon 1.6.10; Bruker microCT) to serial tomograms coronally oriented using 3D cone beam reconstruction algorithms. For these reconstructions, beam hardening was set to 25% and ring artifact reduction to 15. After the scanning, the teeth were aligned and measured in 3D with the DataViewer (Bruker microCT).
| Histological evaluation
The fixed specimens were decalcified using a commercial decalcifying solution (Osteosoft ® ; Merck Millipore, Billerica, MA, USA), which was The obtained results were analyzed with xPonent ® software and were expressed as picograms per milliliter.
| Clinical parameters
At the end of the experiment, right before the rats were killed, the following clinical parameters were recorded in the left first molar of each rat by an experienced periodontist (JG):
Dental plaque index
Selected teeth were smeared with 2% basic fuchsine for 30 seconds and then washed. Teeth were photographed and the size and depth of the purple stain on the tooth were photographed 20 and subsequently measured using the Image Tool3 software. 4 
Gingival index
The Lobene modified gingival index (MGI) was used to record 4 categories of visual inflammatory changes: 0 = absence of any inflammation; 1,2 = mild; 3 = moderate; and 4 = severe. 21 
Probing pocket depth
Probing pocket depth (PPD) was measured from the gingival margin to the bottom of the pocket using a periodontal probe with a round-ended tip of 0.4 mm in diameter (Hu-Friedy Mfg. Co., LLC, Chicago, IL, USA). Using as reference the reported mean PPD value of 0.29 mm in normal rats, 20 periodontitis cases were defined when PPDs were ≥0.5 mm.
22,23
| Micro-computed tomography parameters
For the evaluation of alveolar bone levels, the distance between the cemento-enamel junction and the alveolar bone crest (CEJ-AC) was measured 5 times at 6 different points (mesio-buccal, buccal, distobuccal, disto-lingual, lingual and mesio-lingual) by an independent blinded experienced investigator (JW).
| Histological parameters
Descriptive analysis of the dento-alveolar area of interest evaluated the presence and extent of inflammatory infiltrate and the presence of signs of alveolar bone destruction and osteoclastic activity.
| Data analysis
For all evaluated parameters, their normality was tested using the 
| RE SULTS
| Experimental obesity and periodontitis
Since week 4, animals exposed to high-fat diet presented a significant (P < .01) increase in body weight as compared to animals fed with a standard diet (Figure 1 ). The biochemical effect of this experimental obesity protocol has been recently reported by our research group using an identical methodology. 16, 24 Experimental obesity resulted in statistically significant differences in the evaluated clini- 
| Changes in melatonin concentrations
Melatonin concentrations changed throughout the experimental period in the 4 experimental groups. Figure 2A represents the obtained plasma melatonin concentrations at the end of the experiment. As expected, melatonin levels were significantly reduced in obese animals (HFD and PPD values in mm (ρ = −0.862; P-value = .00). Similar results were obtained for gingival inflammation (MGI) (ρ = −0.478; P-value = .012) and plaque accumulation (PLI) (P-value = .078) ( Figure 2B ,C,D). Table 2) .
| Micro-computed tomography analysis
Percentage increase in body weight of 4 rats groups during the whole experiment. All data are means (SEM) (***P < .001) univariate analysis of variance and independent samples t-test 
| Histological analysis
In the HFD group, the presence of an inflammatory infiltrate in the vicinity of the alveolar bone crest was clearly observed, with the bone surface depicting clear osteoclastic activity ( Figure 4E,F) . A similar histological image was also observed in the Con-Perio group ( Figure 4C ,D) with more evidence of bone destruction when compared with the Con group ( Figure 4A,B) . In the HFD-Perio group the alveolar bone at the bone crest was very thin, with irregular contours and active osteoclastic activity ( Figure 4G,H) . In this group, the presence of an intense inflammatory infiltrate and bone destruction was more evident.
| D ISCUSS I ON
In the present study, the co-morbidity effect after induction of obesity and periodontitis in Wistar rats was clearly demonstrated, with evidence of significantly increased values in the evaluated clinical, microCT and histological parameters associated with periodontitis.
F I G U R E 3
Percentage of alveolar bone loss respect the control group using the mean value of the 6 tooth measurements. ConPerio, Con group with induced periodontitis; HFD, high-fat diet group (fed with a diet containing 35.2% fat); HFD-Perio, HFD group with induced periodontitis All data are means (SEM). B, buccal; Con, control group (fed with standard diet); Con-Perio, Con group with induced periodontitis; DB, disto-buccal; DL, disto-lingual; HFD, highfat diet group (fed with a diet containing 35.2% fat); HFD-Perio, HFD group with induced periodontitis; L, lingual; MB, mesio-buccal; ML, mesio-lingual. In fact, the HFD-Perio group demonstrated deeper periodontal probing depths, more advanced bone loss (higher distance between CEJ and AC in the microCT analysis) and a more intense pathology in the histological evaluation (presence of an intense inflammatory infiltrate and intense osteoclastic activity), when compared with the Con-Perio group and even more evident, when compared with the non-Perio groups (HFD and Con). This co-morbidity effect in the association of obesity and periodontitis has been reported in both experimental and epidemiological studies, which has made some authors proposing obesity as a possible risk factor in the initiation and progression of periodontitis. 1, 25, 26 To explain this association, different underlying mechanisms have been proposed, mainly the effect of systemic inflammation, which is driven by both disease processes and the possible existence of shared risk factors. 27, 28 The possible effect of melatonin, however, was never reported as a possible mechanism explaining this association. In this study, after inducing experimental obesity, the HFD group demonstrated significantly lower plasma melatonin concentrations when compared with the
Con group, what is in agreement with several experimental and clinical studies reporting a melatonin deficiency in obese subjects. 29, 30 This effect of melatonin, can be explained by its active role in the control of the energy balance during the circadian cycle by regulating the flow between storage and expenditure (Chrono disruption) and, therefore, low levels of this key regulator, may be causal for obesity. 11, 31 This study has also reported a significant decrease in plasma melatonin levels in the groups with experimental periodontitis (Con-Perio and HFD-Perio) when compared with the groups without (Con and HFD, respectively). In fact, melatonin concentrations ran inversely proportional to the values of the evaluated periodontal clinical parameters (PPD and MGI). These results are in agreement with epidemiological studies reporting reduced melatonin levels in periodontitis, mainly in cases of aggressive periodontitis.
32,33
The effect of melatonin on periodontal health may be explained by its reported antioxidant and anti-inflammatory properties [33] [34] [35] and its capacity to modulate mitochondrial homeostasis. 36 These effects may be suppressed by the systemic inflammation resulting from periodontitis.
The association of obesity and periodontitis (HFD-Perio group) has shown a synergistic effect in the decline of melatonin circulating levels. Although, the question whether "lower melatonin levels may cause obesity and periodontitis, or these diseases result in lower levels of melatonin" cannot be answered by this experimental research, the results from this investigation clearly demonstrated that the induction of obesity produced a diminution in the circulating melatonin levels. Similarly, after experimental periodontitis, the ConPerio group had significantly lower melatonin levels compared with the Con group without obesity and experimental periodontitis and the HFD-Perio group (obesity + periodontitis) showed statistically significant lower values (P < .05) when compared with the Con-Perio group. These results, therefore demonstrate the co-morbidity effect of obesity and periodontitis on the circulating melatonin levels.
The results from this study, however, should be interpreted with caution, in light of some inherent limitations in its experimental design.
One possible factor is the consistency of the diet, which is different when the standard rat and the hypercaloric diets are compared, that may increase plaque accumulation in the denser diet. Another limitation was that melatonin levels were only analyzed in plasma, and it would have been desirable to measure the local melatonin levels in the gingival tissue, as well as evaluating the expression of melatonin receptors in gingival and adipose tissues. These limitations will hopefully be addressed in future studies. However, in spite of these limitations, an association between melatonin, obesity and periodontitis was established in this in-vivo experimental investigation. Melatonin concentrations were significantly lower in obese and in periodontitis rats compared with controls, but these concentrations were even significantly lower when both diseases coexisted. These results may indicate that melatonin deficiency could be a key mechanism explaining the comorbidity effect in the association between obesity and periodontitis.
Furthermore, the obtained results may hypothesize that the use of melatonin supplements could be beneficial in the treatment of periodontitis in obese subjects. In fact, a number of studies indicate that melatonin has the ability to reduce obesity, type 2 diabetes and liver steatosis. 37 The attainment of melatonin levels in obese subjects has demonstrated improved body weight control, restored adipokine levels and reduced insulin resistance, dyslipidemia and proinflammatory factors and, 38, 39 Further investigations are needed to prove this hypothesis and to evaluate the possible therapeutic effect of melatonin in obese subjects affected by periodontitis.
